Skip to main content
Top
Published in: Endocrine 3/2015

01-04-2015 | Review

Selenium: an element for life

Authors: Leonidas H. Duntas, Salvatore Benvenga

Published in: Endocrine | Issue 3/2015

Login to get access

Abstract

This review aims to illustrate the importance of selenium (Se) for maintenance of overall health, especially for the thyroid, immunity, and homeostasis. Furthermore, it outlines the role of Se in reproduction and in virology and discusses the effects of Se supplementation in critical illness. The multifaceted aspects of this essential nutrient have attracted worldwide clinical and research interest in the last few decades. Se exerts its activity in the form of the aminoacid selenocysteine incorporated in selenoproteins. The impact of Se administration should be considered in relation to its apparent U shaped effects, i.e., exhibiting major advantages in Se-deficient individuals but specific health risks in those with Se excess. Addition of selenium to the administration of levothyroxine may be useful in patients with low Se intake and with mild-form or early-stage Hashimoto’s thyroiditis (HT). Serum Se concentration (possibly also at tissue level) decreases in inflammatory conditions and may vary with the severity and duration of the inflammatory process. In such cases, the effect of Se supplementation seems to be useful and rational. Meanwhile, Se’s ability to improve the activity of T cells and the cytotoxicity of natural killer cells could render it effective in viral disease. However, the evidence, and this should be stressed, is at present conflicting as to whether Se supplementation is of benefit in patients with HT, though there are indications that it is advantageous in cases of mild/moderate Graves’ Orbitopathy. The role of Se in type 2 diabetes mellitus (T2DM) is ambiguous, driven by both Se intake and serum levels. The evidence that insulin and glycaemia influence the transport and activity of Se, via regulatory activity on selenoproteins, and that high serum Se may have a diabetogenic effect suggests a ‘Janus-effect’ of Se in T2DM. Though the evidence is not as yet clear-cut, the organic form (selenomethionine), due to its pharmacokinetics, is likely to be more advantageous in long-term prevention, and supplementation efforts, while the inorganic form (sodium selenite) has proven effective in an acute, e.g., sepsis, clinical setting. Recent data indicate that functional selenoprotein single-nucleotide polymorphisms (SNPs) may interfere with Se utilization and effectiveness.
Literature
1.
go back to reference J.J. Berzelius, Lettre de M. Berzelius à M. Berthollet sur deux nouveaux métaux (Letter from Mr. Berzelius to Mr. Berthollet on two new metals). Annales Chimie et Physique 187, 199–200 (1817) J.J. Berzelius, Lettre de M. Berzelius à M. Berthollet sur deux nouveaux métaux (Letter from Mr. Berzelius to Mr. Berthollet on two new metals). Annales Chimie et Physique 187, 199–200 (1817)
2.
go back to reference W. von Gümbel, M. von Reichenstein, F.J. Freiherr, Allgemeine Deutsche Biographie (ADB) (in German) 22, Leipzig: Duncker & Humblot 702–703 (1885) W. von Gümbel, M. von Reichenstein, F.J. Freiherr, Allgemeine Deutsche Biographie (ADB) (in German) 22, Leipzig: Duncker & Humblot 702–703 (1885)
3.
go back to reference R. Meyer, Martin Heinrich Klaproth, ein deutscher Chemiker des 18. Jahrhunderts. Zeitschrift für Angewandte Chemie 34, 1–3 (1921) R. Meyer, Martin Heinrich Klaproth, ein deutscher Chemiker des 18. Jahrhunderts. Zeitschrift für Angewandte Chemie 34, 1–3 (1921)
4.
go back to reference K. Schwarz, C.M. Foltz, Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292–3293 (1957) K. Schwarz, C.M. Foltz, Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292–3293 (1957)
5.
go back to reference K.M. Brown, R. Arthur, Selenium, selenoproteins and human health: a review. Public Health Nutr. 4, 593–599 (2001)PubMed K.M. Brown, R. Arthur, Selenium, selenoproteins and human health: a review. Public Health Nutr. 4, 593–599 (2001)PubMed
7.
go back to reference C.D. Thomson, M.F. Robinson, Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am. J. Clin. Nutr. 33, 303–323 (1980)PubMed C.D. Thomson, M.F. Robinson, Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am. J. Clin. Nutr. 33, 303–323 (1980)PubMed
8.
go back to reference C.D. Thomson, M.F. Robinson, Selenium content of foods consumed in Otago, New Zealand. N Z Med. J. 103(886), 130–135 (1990)PubMed C.D. Thomson, M.F. Robinson, Selenium content of foods consumed in Otago, New Zealand. N Z Med. J. 103(886), 130–135 (1990)PubMed
10.
go back to reference W. Wasowicz, J. Gromadzinska, K. Rydzynski, J. Tomczak, Selenium status of low-selenium area residents: polish experience. Toxicol. Lett. 137, 95–101 (2003)PubMed W. Wasowicz, J. Gromadzinska, K. Rydzynski, J. Tomczak, Selenium status of low-selenium area residents: polish experience. Toxicol. Lett. 137, 95–101 (2003)PubMed
11.
go back to reference F. Gondi, G. Pantó, J. Fehér, G. Bogye, G. Alfthan, Selenium in Hungary. The rock-soil-human system. Biol. Trace Elem. Res. 35, 299–306 (1992)PubMed F. Gondi, G. Pantó, J. Fehér, G. Bogye, G. Alfthan, Selenium in Hungary. The rock-soil-human system. Biol. Trace Elem. Res. 35, 299–306 (1992)PubMed
12.
go back to reference G.F. Jr, Combs, Selenium in global food systems. Br. J. Nutr. 85, 517–547 (2001) G.F. Jr, Combs, Selenium in global food systems. Br. J. Nutr. 85, 517–547 (2001)
13.
go back to reference C. Thiry, A. Ruttens, L. Pussemier, Y.J. Schneider, An in vitro investigation of species-dependent intestinal transport of selenium and the impact of this process on selenium bioavailability. Br. J. Nutr. 109, 2126–2134 (2013). doi:10.1017/S0007114512004412 PubMed C. Thiry, A. Ruttens, L. Pussemier, Y.J. Schneider, An in vitro investigation of species-dependent intestinal transport of selenium and the impact of this process on selenium bioavailability. Br. J. Nutr. 109, 2126–2134 (2013). doi:10.​1017/​S000711451200441​2 PubMed
14.
go back to reference C.M. Weekley, H.H. Harris, Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 42, 8870–8894 (2013)PubMed C.M. Weekley, H.H. Harris, Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 42, 8870–8894 (2013)PubMed
16.
go back to reference Y. Kobayashi, Y. Ogra, K. Ishiwata, H. Takayama, N. Aimi, K.T. Suzuki, Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Proc. Natl. Acad. Sci. USA. 99, 15932–15936 (2002)PubMedCentralPubMed Y. Kobayashi, Y. Ogra, K. Ishiwata, H. Takayama, N. Aimi, K.T. Suzuki, Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Proc. Natl. Acad. Sci. USA. 99, 15932–15936 (2002)PubMedCentralPubMed
17.
go back to reference N. Waegeneers, C. Thiry, L. De Temmerman, A. Ruttens, Predicted dietary intake of selenium by the general adult population in Belgium. Food Addit. Contam. Part A. Chem. Anal. Control Expo. Risk Assess. 30, 278–285 doi:10.1080/19440049.2012.746474 (2013) N. Waegeneers, C. Thiry, L. De Temmerman, A. Ruttens, Predicted dietary intake of selenium by the general adult population in Belgium. Food Addit. Contam. Part A. Chem. Anal. Control Expo. Risk Assess. 30, 278–285 doi:10.​1080/​19440049.​2012.​746474 (2013)
18.
go back to reference K. Park, E. Rimm, D. Siscovick, D. Spiegelman, J.S. Morris, D. Mozaffarian, Demographic and lifestyle factors and selenium levels in men and women in the U.S. Nutr. Res. Pract. 5, 357–364 (2011). doi: 10.4162/nrp.2011.5.4.357 K. Park, E. Rimm, D. Siscovick, D. Spiegelman, J.S. Morris, D. Mozaffarian, Demographic and lifestyle factors and selenium levels in men and women in the U.S. Nutr. Res. Pract. 5, 357–364 (2011). doi: 10.​4162/​nrp.​2011.​5.​4.​357
19.
go back to reference M. Spadoni, M. Voltaggio, M. Carcea, E. Coni, A. Raggi, F. Cubadda, Bioaccessible selenium in Italian agricultural soils: comparison of the biogeochemical approach with a regression model based on geochemical and pedoclimatic variables. Sci. Total Environ. 376, 160–177 (2007)PubMed M. Spadoni, M. Voltaggio, M. Carcea, E. Coni, A. Raggi, F. Cubadda, Bioaccessible selenium in Italian agricultural soils: comparison of the biogeochemical approach with a regression model based on geochemical and pedoclimatic variables. Sci. Total Environ. 376, 160–177 (2007)PubMed
20.
go back to reference J.W. Finley, Bioavailability of selenium from foods. Nutr. Rev. 64, 146–151 (2006)PubMed J.W. Finley, Bioavailability of selenium from foods. Nutr. Rev. 64, 146–151 (2006)PubMed
21.
go back to reference J.M. Finley, M.A. Grusak, A.S. Keck, B.R. Gregoire, Bioavailability of selenium from meat and broccoli as determined by retention and distribution of 75Se. Biol. Trace Elem. Res. 99, 191–209 (2004)PubMed J.M. Finley, M.A. Grusak, A.S. Keck, B.R. Gregoire, Bioavailability of selenium from meat and broccoli as determined by retention and distribution of 75Se. Biol. Trace Elem. Res. 99, 191–209 (2004)PubMed
22.
go back to reference A. Haug, R.D. Graham, O.A. Christophersen, G.H. Lyons, How to use the world’s scarce selenium resources efficiently to increase the selenium concentration in food. Microb Ecol Health Dis. 19, 209–228 (2007)PubMedCentralPubMed A. Haug, R.D. Graham, O.A. Christophersen, G.H. Lyons, How to use the world’s scarce selenium resources efficiently to increase the selenium concentration in food. Microb Ecol Health Dis. 19, 209–228 (2007)PubMedCentralPubMed
23.
go back to reference Keshan Disease Research Group, Epidemiological studies on the etiologic relationship of selenium in Keshan disease. Chin. Med. J. 92, 471–476 (1979) Keshan Disease Research Group, Epidemiological studies on the etiologic relationship of selenium in Keshan disease. Chin. Med. J. 92, 471–476 (1979)
25.
go back to reference B. Contempre, G. Morreale de Escobar, J.F. Denef, J.E. Dumont, M.C. Many, Thiocyanate induces cell necrosis and fibrosis in selenium- and iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. Endocrinology 145, 994–1002 (2004)PubMed B. Contempre, G. Morreale de Escobar, J.F. Denef, J.E. Dumont, M.C. Many, Thiocyanate induces cell necrosis and fibrosis in selenium- and iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. Endocrinology 145, 994–1002 (2004)PubMed
26.
go back to reference J.E. Dumont, B. Corvilain, B. Contempre, The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol. Cell. Endocrinol. 100, 163–166 (1994)PubMed J.E. Dumont, B. Corvilain, B. Contempre, The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol. Cell. Endocrinol. 100, 163–166 (1994)PubMed
27.
go back to reference G. Yang, L. Zhu, S. Liu, Human selenium requirements in China, in Selenium in biology and medicine, eds. by G.F. Combs, J.E. Spallholz, O.A. Levander, J.E. Oldfield (eds.) (Nostrand Rheinhold/AVI, New York, 1987) pp.589–607 G. Yang, L. Zhu, S. Liu, Human selenium requirements in China, in Selenium in biology and medicine, eds. by G.F. Combs, J.E. Spallholz, O.A. Levander, J.E. Oldfield (eds.) (Nostrand Rheinhold/AVI, New York, 1987) pp.589–607
28.
go back to reference M.F. Robinson, The New Zealand selenium experience. Am. J. Clin. Nutr. 48, 521–534 (1989) M.F. Robinson, The New Zealand selenium experience. Am. J. Clin. Nutr. 48, 521–534 (1989)
29.
go back to reference J.T. Salonen, G. Alfthan, J.K. Huttunen, J. Pikkarainen, P. Puska, Association between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet 2, 175–179 (1982)PubMed J.T. Salonen, G. Alfthan, J.K. Huttunen, J. Pikkarainen, P. Puska, Association between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet 2, 175–179 (1982)PubMed
30.
go back to reference J. Virtamo, E. Valkeila, G. Alfthan, S. Punsar, J.K. Huttunen, M.J. Karvonen, Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122, 276–282 (1985)PubMed J. Virtamo, E. Valkeila, G. Alfthan, S. Punsar, J.K. Huttunen, M.J. Karvonen, Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122, 276–282 (1985)PubMed
31.
go back to reference B. Lloyd, R.S. Loyd, B.E. Clayton, Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J. Epidemiol. Commun. Health 37, 213–217 (1983) B. Lloyd, R.S. Loyd, B.E. Clayton, Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J. Epidemiol. Commun. Health 37, 213–217 (1983)
32.
go back to reference Commission of the European Communities, Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, thirty first series, Office for Official Publications of the European Communities, Luxembourg (1993) Commission of the European Communities, Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, thirty first series, Office for Official Publications of the European Communities, Luxembourg (1993)
33.
go back to reference Italian Society of Human Nutrition, Document Revision 2012 RDAs (Reference Levels of Nutrients intake and energy for the Italian population) of the Italian Society of Human Nutrition (XXXV Congress SINU, Bologna 22–23 October 2012) Italian Society of Human Nutrition, Document Revision 2012 RDAs (Reference Levels of Nutrients intake and energy for the Italian population) of the Italian Society of Human Nutrition (XXXV Congress SINU, Bologna 22–23 October 2012)
34.
go back to reference Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. (National Academy Press, Washington, DC, 2000), pp 284–324 Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. (National Academy Press, Washington, DC, 2000), pp 284–324
35.
go back to reference M. Mihajlovic, Selenium toxicity in domestic animals. Glas. Srp. Akad. Nauka. Med. 42, 131–144 (1992)PubMed M. Mihajlovic, Selenium toxicity in domestic animals. Glas. Srp. Akad. Nauka. Med. 42, 131–144 (1992)PubMed
36.
go back to reference S. Shao, B. Zheng, The biogeochemistry of selenium in Sunan grassland, Gansu, Northwest China, casts doubt on the belief that Marco Polo reported selenosis for the first time in history. Environ. Geochem. Health 30, 307–314 (2008)PubMed S. Shao, B. Zheng, The biogeochemistry of selenium in Sunan grassland, Gansu, Northwest China, casts doubt on the belief that Marco Polo reported selenosis for the first time in history. Environ. Geochem. Health 30, 307–314 (2008)PubMed
37.
go back to reference J.S. Morris, S.B. Crane, Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 5, 1024–1057 (2013)PubMedCentralPubMed J.S. Morris, S.B. Crane, Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 5, 1024–1057 (2013)PubMedCentralPubMed
38.
go back to reference K. Helzslouer, R. Jacobs, S. Morris, Acute selenium intoxication in the United States. Fed. Proc. 44, 1670 (1985) K. Helzslouer, R. Jacobs, S. Morris, Acute selenium intoxication in the United States. Fed. Proc. 44, 1670 (1985)
39.
go back to reference J.K. McFarquhar, D.L. Broussard, P. Melstrom, R. Hutchinson, A. Wolkin, C. Martin, R.F. Burk, J.R. Dunn, A.L. Green, R. Hammond, W. Schaffner, T.F. Jones, Acute selenium toxicity associated with a dietary supplement. Arch. Int. Med. 170, 256–261 (2010) J.K. McFarquhar, D.L. Broussard, P. Melstrom, R. Hutchinson, A. Wolkin, C. Martin, R.F. Burk, J.R. Dunn, A.L. Green, R. Hammond, W. Schaffner, T.F. Jones, Acute selenium toxicity associated with a dietary supplement. Arch. Int. Med. 170, 256–261 (2010)
40.
go back to reference B.M. Aldosary, M.E. Sutter, M. Schwartz, B.M. Morgan, Case series of selenium toxicity from a nutritional supplement. Clin. Toxicol. (Philadelphia, Pa.) 50, 57–64 (2012) B.M. Aldosary, M.E. Sutter, M. Schwartz, B.M. Morgan, Case series of selenium toxicity from a nutritional supplement. Clin. Toxicol. (Philadelphia, Pa.) 50, 57–64 (2012)
41.
go back to reference G. Yang, S. Wang, R. Zhou, S. Sun, Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 37, 872–881 (1983)PubMed G. Yang, S. Wang, R. Zhou, S. Sun, Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 37, 872–881 (1983)PubMed
42.
go back to reference G. Yang, S. Yin, L. Zhou, Studies of safe maximal dietary Se intake in a seleniferous area in China. Part II. Relation between Se intake and the manifestation of clinical signs and certain biochemical alterations in blood and urine. J. Trace Elem. Electrol. Health Dis. 3, 123–130 (1989) G. Yang, S. Yin, L. Zhou, Studies of safe maximal dietary Se intake in a seleniferous area in China. Part II. Relation between Se intake and the manifestation of clinical signs and certain biochemical alterations in blood and urine. J. Trace Elem. Electrol. Health Dis. 3, 123–130 (1989)
43.
go back to reference S. Huang, M. Hua, J. Feng, X. Zhong, Y. Jin, B. Zhu, H. Lu, Assessment of selenium pollution in agricultural soils in the Xuzhou District, Northwest Jiangsu, China. J. Environ. Sci. (China) 21, 481–487 (2009) S. Huang, M. Hua, J. Feng, X. Zhong, Y. Jin, B. Zhu, H. Lu, Assessment of selenium pollution in agricultural soils in the Xuzhou District, Northwest Jiangsu, China. J. Environ. Sci. (China) 21, 481–487 (2009)
44.
go back to reference M.E. Reid, M.S. Stratton, A.J. Lillico, M. Fakih, R. Natarajan, L.C. Clark, J.R. Marshall, A report of high-dose selenium supplementation: response and toxicities. J. Trace Elem. Med Biol. 18, 69–74 (2004)PubMed M.E. Reid, M.S. Stratton, A.J. Lillico, M. Fakih, R. Natarajan, L.C. Clark, J.R. Marshall, A report of high-dose selenium supplementation: response and toxicities. J. Trace Elem. Med Biol. 18, 69–74 (2004)PubMed
45.
go back to reference M. Vinceti, G. Dennert, C.M. Crespi, M. Zwahlen, M. Brinkman, M.P. Zeegers, M. Horneber, R. D’Amico, C. Del Giovane C. Selenium for preventing cancer. Cochrane Database Syst Rev. 30;3:CD005195 (2014). doi:10.1002/14651858.CD005195.pub3 M. Vinceti, G. Dennert, C.M. Crespi, M. Zwahlen, M. Brinkman, M.P. Zeegers, M. Horneber, R. D’Amico, C. Del Giovane C. Selenium for preventing cancer. Cochrane Database Syst Rev. 30;3:CD005195 (2014). doi:10.​1002/​14651858.​CD005195.​pub3
46.
go back to reference M. Vinceti, F. Bonvicini, K.J. Rothman, L. Vescovi, F. Wang, The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ. Health. 9, 77 (2010). doi:10.1186/1476-069X-9-77 PubMedCentralPubMed M. Vinceti, F. Bonvicini, K.J. Rothman, L. Vescovi, F. Wang, The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ. Health. 9, 77 (2010). doi:10.​1186/​1476-069X-9-77 PubMedCentralPubMed
47.
go back to reference M. Ben-Porath, L. Case, E. Kaplan. The biological half-life of 75Se selenomethionine in man. J. Nucl. Med. 9, 168–169 (l968) M. Ben-Porath, L. Case, E. Kaplan. The biological half-life of 75Se selenomethionine in man. J. Nucl. Med. 9, 168–169 (l968)
48.
go back to reference C.A. Swanson, B.H. Patterson, O.A. Levander, C. Veillon, P.R. Taylor, K. Helzlsouer, P.A. McAdam, L.A. Zech, Human [74Se] selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr. 54, 917–926 (1991)PubMed C.A. Swanson, B.H. Patterson, O.A. Levander, C. Veillon, P.R. Taylor, K. Helzlsouer, P.A. McAdam, L.A. Zech, Human [74Se] selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr. 54, 917–926 (1991)PubMed
49.
go back to reference B.H. Patterson, O.A. Levander, K. Helzlsouer, P.A. McAdam, S.A. Lewis, P.R. Taylor, C. Veillon, L.A. Zech, Human selenite metabolism: a kinetic model. Am. J. Physiol. 257, R556–R567 (1989)PubMed B.H. Patterson, O.A. Levander, K. Helzlsouer, P.A. McAdam, S.A. Lewis, P.R. Taylor, C. Veillon, L.A. Zech, Human selenite metabolism: a kinetic model. Am. J. Physiol. 257, R556–R567 (1989)PubMed
50.
go back to reference C.D. Thomson, C.E. Burton, M.F. Robinson, On supplementing the selenium intake of New Zealanders. I. Short experiments with large doses of selenite or selenomethionine. Br. J. Nutr. 39, 579–587 (1978)PubMed C.D. Thomson, C.E. Burton, M.F. Robinson, On supplementing the selenium intake of New Zealanders. I. Short experiments with large doses of selenite or selenomethionine. Br. J. Nutr. 39, 579–587 (1978)PubMed
51.
go back to reference M.F. Robinson, H.M. Rca, G.M. Friend, R.D.H. Stewart, P.C. Snow, C.D. Thomson, On supplementing the selenium intake of New Zealanders. 2. Prolonged metabolic experiments with daily supplements of selenomethionine, selenite and fish. Br. J. Nutr. 39, 589–600 (1978)PubMed M.F. Robinson, H.M. Rca, G.M. Friend, R.D.H. Stewart, P.C. Snow, C.D. Thomson, On supplementing the selenium intake of New Zealanders. 2. Prolonged metabolic experiments with daily supplements of selenomethionine, selenite and fish. Br. J. Nutr. 39, 589–600 (1978)PubMed
52.
go back to reference M.E. Wastney, G.F. Combs Jr, W.K. Canfield, P.R. Taylor, K.Y. Patterson, A.D. Hill, J.E. Moler, B.H. Patterson, A human model of selenium that integrates metabolism from selenite and selenomethionine. J. Nutr. 141, 708–717 (2011). doi:10.3945/jn.110.129049 PubMedCentralPubMed M.E. Wastney, G.F. Combs Jr, W.K. Canfield, P.R. Taylor, K.Y. Patterson, A.D. Hill, J.E. Moler, B.H. Patterson, A human model of selenium that integrates metabolism from selenite and selenomethionine. J. Nutr. 141, 708–717 (2011). doi:10.​3945/​jn.​110.​129049 PubMedCentralPubMed
53.
go back to reference B. Gammelgaard, L.H. Rasmussen, C. Gabel-Jensen, B. Steffansen, Estimating intestinal absorption of inorganic and organic selenium compounds by in vitro flux and biotransformation studies in Caco-2 cells and ICP-MS detection. Biol. Trace Elem. Res. 145, 248–256 (2012). doi:10.1007/s12011-011-9174-y PubMed B. Gammelgaard, L.H. Rasmussen, C. Gabel-Jensen, B. Steffansen, Estimating intestinal absorption of inorganic and organic selenium compounds by in vitro flux and biotransformation studies in Caco-2 cells and ICP-MS detection. Biol. Trace Elem. Res. 145, 248–256 (2012). doi:10.​1007/​s12011-011-9174-y PubMed
54.
go back to reference M.J. Berry, L. Banu, Y.Y. Chen, S.J. Mandel, J.D. Kieffer, J.W. Harney, P.R. Larsen, Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353, 273–276 (1991)PubMed M.J. Berry, L. Banu, Y.Y. Chen, S.J. Mandel, J.D. Kieffer, J.W. Harney, P.R. Larsen, Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353, 273–276 (1991)PubMed
56.
go back to reference M.J. Berry, L. Banu, J.W. Harney, P.R. Larsen, Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 12, 3315–3322 (1993)PubMedCentralPubMed M.J. Berry, L. Banu, J.W. Harney, P.R. Larsen, Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 12, 3315–3322 (1993)PubMedCentralPubMed
57.
go back to reference J. Köhrle, F. Jakob, B. Contempré, J.E. Dumont, Selenium, the thyroid and the endocrine system. Endocr. Rev. 26, 944–984 (2005)PubMed J. Köhrle, F. Jakob, B. Contempré, J.E. Dumont, Selenium, the thyroid and the endocrine system. Endocr. Rev. 26, 944–984 (2005)PubMed
58.
go back to reference M.J. Berry, L. Banu, P.R. Larsen, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349, 438–440 (1991)PubMed M.J. Berry, L. Banu, P.R. Larsen, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349, 438–440 (1991)PubMed
59.
go back to reference A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, P.R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002)PubMed A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, P.R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002)PubMed
60.
go back to reference U. Schweizer, F. Streckfuss, P. Pelt, B.A. Carlson, D.L. Hartfeld, J. Koehrle, L. Schomburg, Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386, 221–226 (2005)PubMedCentralPubMed U. Schweizer, F. Streckfuss, P. Pelt, B.A. Carlson, D.L. Hartfeld, J. Koehrle, L. Schomburg, Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386, 221–226 (2005)PubMedCentralPubMed
61.
go back to reference K.E. Hill, S. Wu, A.K. Motley, T.D. Stevenson, V.P. Winfrey, M.R. Capecchi, J.F. Atkins, R.F. Burk, Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J. Biol. Chem. 287, 40414–40424 (2012). doi:10.1074/jbc.M112.421404 PubMedCentralPubMed K.E. Hill, S. Wu, A.K. Motley, T.D. Stevenson, V.P. Winfrey, M.R. Capecchi, J.F. Atkins, R.F. Burk, Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J. Biol. Chem. 287, 40414–40424 (2012). doi:10.​1074/​jbc.​M112.​421404 PubMedCentralPubMed
62.
go back to reference K. Renko, M. Werner, I. Renner-Müller, T.G. Cooper, C.H. Yeung, B. Hollenbach, M. Scharpf, J. Köhrle, L. Schomburg, U. Schweizer, Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem. J. 409, 741–749 (2008)PubMed K. Renko, M. Werner, I. Renner-Müller, T.G. Cooper, C.H. Yeung, B. Hollenbach, M. Scharpf, J. Köhrle, L. Schomburg, U. Schweizer, Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem. J. 409, 741–749 (2008)PubMed
63.
go back to reference K.E. Hill, J. Zhou, W.J. McMahan, A.K. Motley, R.F. Burk, Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J. Nutr. 134, 157–161 (2004)PubMed K.E. Hill, J. Zhou, W.J. McMahan, A.K. Motley, R.F. Burk, Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J. Nutr. 134, 157–161 (2004)PubMed
64.
go back to reference J. Mittag, T. Behrends, C.S. Hoefig, B. Vennström, L. Schomburg, Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS One 5, e12931 (2010)PubMedCentralPubMed J. Mittag, T. Behrends, C.S. Hoefig, B. Vennström, L. Schomburg, Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS One 5, e12931 (2010)PubMedCentralPubMed
65.
go back to reference N. Karunasinghe, D.Y. Han, S. Zhu, J. Yu, K. Lange, H. Duan, R. Medhora, N. Singh, J. Kan, W. Alzaher, B. Chen, S. Ko, C.M. Triggs, L.R. Ferguson, Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr. 7, 179–190 (2012)PubMedCentralPubMed N. Karunasinghe, D.Y. Han, S. Zhu, J. Yu, K. Lange, H. Duan, R. Medhora, N. Singh, J. Kan, W. Alzaher, B. Chen, S. Ko, C.M. Triggs, L.R. Ferguson, Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr. 7, 179–190 (2012)PubMedCentralPubMed
66.
go back to reference C. Méplan, L.K. Crosley, F. Nicol, G.J. Beckett, A.F. Howie, K.E. Hill, G. Horgan, J.C. Mathers, J.R. Arthur, J.E. Hesketh, Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 21, 3063–3074 (2007)PubMed C. Méplan, L.K. Crosley, F. Nicol, G.J. Beckett, A.F. Howie, K.E. Hill, G. Horgan, J.C. Mathers, J.R. Arthur, J.E. Hesketh, Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 21, 3063–3074 (2007)PubMed
67.
go back to reference N. Karunasinghe, D.Y. Han, S. Zhu, H. Duan, Y.J. Ko, J.F. Yu, C.M. Triggs, L.R. Ferguson, Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr. Cancer 65, 355–366 (2013). doi:10.1080/01635581.2013.760743 PubMed N. Karunasinghe, D.Y. Han, S. Zhu, H. Duan, Y.J. Ko, J.F. Yu, C.M. Triggs, L.R. Ferguson, Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr. Cancer 65, 355–366 (2013). doi:10.​1080/​01635581.​2013.​760743 PubMed
68.
go back to reference J. Aaseth, H. Frey, E. Glattre, G. Norheim, J. Ringstad, Y. Thomassen, Selenium concentration in the human thyroid gland. Biol. Trace Elem. Res. 24, 147–152 (1990)PubMed J. Aaseth, H. Frey, E. Glattre, G. Norheim, J. Ringstad, Y. Thomassen, Selenium concentration in the human thyroid gland. Biol. Trace Elem. Res. 24, 147–152 (1990)PubMed
69.
go back to reference B. Tiran, E. Karpf, A. Tiran, Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch. Environ. Health 50, 242–246 (1995)PubMed B. Tiran, E. Karpf, A. Tiran, Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch. Environ. Health 50, 242–246 (1995)PubMed
70.
go back to reference J. Koehrle, The trace element selenium and the thyroid gland. Biochimie 81, 527–533 (1999) J. Koehrle, The trace element selenium and the thyroid gland. Biochimie 81, 527–533 (1999)
71.
go back to reference G.J. Beckett, J.R. Arthur, Selenium and endocrine systems. J. Endocrinol. 184, 455–465 (2005)PubMed G.J. Beckett, J.R. Arthur, Selenium and endocrine systems. J. Endocrinol. 184, 455–465 (2005)PubMed
72.
go back to reference L. Flohé, K.-D. Aumann, P. Steinert P. Role of selenium in the enzymatic reduction of hydroperoxides. Phosphorus Orous Sulfur Silicon. 136-138, 25–42 (1998) L. Flohé, K.-D. Aumann, P. Steinert P. Role of selenium in the enzymatic reduction of hydroperoxides. Phosphorus Orous Sulfur Silicon. 136-138, 25–42 (1998)
73.
go back to reference L. Tan, Z.N. Sang, J. Shen, Y.T. Wu, Z.X. Yao, J.X. Zhang, N. Zhao, W.Q. Zhang, Selenium supplementation alleviates autoimmune thyroiditis by regulating expression of TH1/TH2 cytokines. Biomed. Environ. Sci. 26, 920–925 (2013). doi:10.3967/bes2013.022 PubMed L. Tan, Z.N. Sang, J. Shen, Y.T. Wu, Z.X. Yao, J.X. Zhang, N. Zhao, W.Q. Zhang, Selenium supplementation alleviates autoimmune thyroiditis by regulating expression of TH1/TH2 cytokines. Biomed. Environ. Sci. 26, 920–925 (2013). doi:10.​3967/​bes2013.​022 PubMed
75.
go back to reference G.J. Beckett, S.E. Beddows, P.C. Morrice, F. Nicol, J.R. Arthur, Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem. J. 248, 443–447 (2003) G.J. Beckett, S.E. Beddows, P.C. Morrice, F. Nicol, J.R. Arthur, Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem. J. 248, 443–447 (2003)
76.
go back to reference J. Chiu-Ugalde, E.K. Wirth, M.O. Klein, R. Sapin, N. Fradejas-Villar, K. Renko, L. Schomburg, J. Köhrle, U. Schweizer, Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid. Redox Signal. 17, 902–913 (2012). doi:10.1089/ars.2011.4055 PubMed J. Chiu-Ugalde, E.K. Wirth, M.O. Klein, R. Sapin, N. Fradejas-Villar, K. Renko, L. Schomburg, J. Köhrle, U. Schweizer, Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid. Redox Signal. 17, 902–913 (2012). doi:10.​1089/​ars.​2011.​4055 PubMed
77.
go back to reference S.J. Tsai, U. Sen, L. Zhao, W.B. Greenleaf, J. Dasgupta, E. Fiorillo, V. Orrú, N. Bottini, X.S. Chen, Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation. Biochem. 48, 4838–4845 (2009) S.J. Tsai, U. Sen, L. Zhao, W.B. Greenleaf, J. Dasgupta, E. Fiorillo, V. Orrú, N. Bottini, X.S. Chen, Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation. Biochem. 48, 4838–4845 (2009)
78.
go back to reference B. Contempré, J.E. Dumont, N. Bebe, C.H. Thilly, A.T. Diplock, J. Vanderpas, Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab. 73, 213–215 (1991)PubMed B. Contempré, J.E. Dumont, N. Bebe, C.H. Thilly, A.T. Diplock, J. Vanderpas, Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab. 73, 213–215 (1991)PubMed
79.
go back to reference B. Contempré, O. Le Moine, J.E. Dumont, J.F. Denef, M.C. Many, Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol. Cell. Endocrinol. 124, 7–15 (1996)PubMed B. Contempré, O. Le Moine, J.E. Dumont, J.F. Denef, M.C. Many, Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol. Cell. Endocrinol. 124, 7–15 (1996)PubMed
80.
go back to reference J.B. Vanderpas, B. Contempré, N.L. Duale, H. Deckx, N. Bebe, A.O. Longombé, C.H. Thilly, A.T. Diplock, J.E. Dumont, Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am. J. Clin. Nutr. 57, 271S–275S (1993)PubMed J.B. Vanderpas, B. Contempré, N.L. Duale, H. Deckx, N. Bebe, A.O. Longombé, C.H. Thilly, A.T. Diplock, J.E. Dumont, Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am. J. Clin. Nutr. 57, 271S–275S (1993)PubMed
81.
go back to reference G. Karanikas, M. Schuetz, S. Kontur, H. Duan, S. Kommata, R. Schoen, A. Antoni, K. Kletter, R. Dudczak, M. Willheim, No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 18, 7–12 (2008)PubMed G. Karanikas, M. Schuetz, S. Kontur, H. Duan, S. Kommata, R. Schoen, A. Antoni, K. Kletter, R. Dudczak, M. Willheim, No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 18, 7–12 (2008)PubMed
82.
go back to reference W. Bonfig, R. Gärtner, H. Schmidt, Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Sci. World J. 10, 990–996 (2010) W. Bonfig, R. Gärtner, H. Schmidt, Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Sci. World J. 10, 990–996 (2010)
83.
go back to reference S.A. Eskes, E. Endert, E. Fliers, E. Birnie, B. Hollenbach, L. Schomburg, J. Köhrle, W.M. Wiersinga, Selenite supplementation in euthyroids subjects with thyroid peroxidase antibodies. Clin. Endocrinol. (Oxf) (2013). doi:10.1111/cen.12284 S.A. Eskes, E. Endert, E. Fliers, E. Birnie, B. Hollenbach, L. Schomburg, J. Köhrle, W.M. Wiersinga, Selenite supplementation in euthyroids subjects with thyroid peroxidase antibodies. Clin. Endocrinol. (Oxf) (2013). doi:10.​1111/​cen.​12284
84.
go back to reference R. Gärtner, B.C. Gasnier, J.W. Dietrich, B. Krebs, M.W. Angstwurm, Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687–1691 (2002)PubMed R. Gärtner, B.C. Gasnier, J.W. Dietrich, B. Krebs, M.W. Angstwurm, Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687–1691 (2002)PubMed
85.
go back to reference R. Gärtner, B.C. Gasnier, Selenium in the treatment of autoimmune thyroiditis. BioFactors 19, 165–170 (2003)PubMed R. Gärtner, B.C. Gasnier, Selenium in the treatment of autoimmune thyroiditis. BioFactors 19, 165–170 (2003)PubMed
86.
go back to reference D. Nacamulli, C. Mian, D. Petricca, F. Lazzarotto, S. Barollo, D. Pozza, S. Masiero, D. Faggian, M. Plebani, M.E. Girelli, F. Mantero, C. Betterle, Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol. (Oxf) 73, 535–539 (2010) D. Nacamulli, C. Mian, D. Petricca, F. Lazzarotto, S. Barollo, D. Pozza, S. Masiero, D. Faggian, M. Plebani, M.E. Girelli, F. Mantero, C. Betterle, Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol. (Oxf) 73, 535–539 (2010)
87.
go back to reference R. Negro, G. Greco, T. Mangieri, A. Pezzarossa, D. Dazzi, H. Hassan, The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab. 92, 1263–1268 (2007)PubMed R. Negro, G. Greco, T. Mangieri, A. Pezzarossa, D. Dazzi, H. Hassan, The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab. 92, 1263–1268 (2007)PubMed
88.
go back to reference L.H. Duntas, E. Mantzou, D.A. Koutras, Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148, 389–393 (2003)PubMed L.H. Duntas, E. Mantzou, D.A. Koutras, Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148, 389–393 (2003)PubMed
89.
go back to reference E.E. Mazokopakis, J.A. Papadakis, M.G. Papadomanolaki, A.G. Batistakis, T.G. Giannakopoulos, E.E. Protopapadakis, E.S. Ganotakis, Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid. 17, 609–612 (2007)PubMed E.E. Mazokopakis, J.A. Papadakis, M.G. Papadomanolaki, A.G. Batistakis, T.G. Giannakopoulos, E.E. Protopapadakis, E.S. Ganotakis, Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid. 17, 609–612 (2007)PubMed
90.
go back to reference O. Turker, K. Kumanlioglu, I. Karapolat, I. Dogan, The Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 190, 151–156 (2006)PubMed O. Turker, K. Kumanlioglu, I. Karapolat, I. Dogan, The Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 190, 151–156 (2006)PubMed
91.
go back to reference C. Balázs, The effect of selenium therapy on autoimmune thyroiditis. Orv. Hetil. 149, 1227–1232 (2008)PubMed C. Balázs, The effect of selenium therapy on autoimmune thyroiditis. Orv. Hetil. 149, 1227–1232 (2008)PubMed
92.
go back to reference L. Zhu, X. Bai, W.P. Teng, Z.Y. Shan, W.W. Wang, C.L. Fan, H. Wang, H.M. Zhang, Effects of selenium supplementation on antibodies of autoimmune thyroiditis. Zhonghua Yi Xue Za Zhi 92, 2256–2260 (2012)PubMed L. Zhu, X. Bai, W.P. Teng, Z.Y. Shan, W.W. Wang, C.L. Fan, H. Wang, H.M. Zhang, Effects of selenium supplementation on antibodies of autoimmune thyroiditis. Zhonghua Yi Xue Za Zhi 92, 2256–2260 (2012)PubMed
93.
go back to reference K.A. Toulis, A.D. Anastasilakis, T.G. Tzellos, D.G. Goulis, D. Kouvelas, Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163–1173 (2010)PubMed K.A. Toulis, A.D. Anastasilakis, T.G. Tzellos, D.G. Goulis, D. Kouvelas, Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163–1173 (2010)PubMed
94.
go back to reference E.J. van Zuuren, A.Y. Albusta, Z. Fedorowicz, B. Carter, H. Pijl, Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst. Rev. 6, CD01:0223 (2013) E.J. van Zuuren, A.Y. Albusta, Z. Fedorowicz, B. Carter, H. Pijl, Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst. Rev. 6, CD01:0223 (2013)
95.
go back to reference L.H. Duntas, Selenium and the thyroid: a close-knit connection. J. Clin. Endocrinol. Metab. 95, 5180–5188 (2010)PubMed L.H. Duntas, Selenium and the thyroid: a close-knit connection. J. Clin. Endocrinol. Metab. 95, 5180–5188 (2010)PubMed
96.
go back to reference D. Nacamulli, D. Petricca, C. Mian, Selenium and autoimmune thyroiditis. J. Endocrinol. Invest. 36(10 Suppl), 8–14 (2013)PubMed D. Nacamulli, D. Petricca, C. Mian, Selenium and autoimmune thyroiditis. J. Endocrinol. Invest. 36(10 Suppl), 8–14 (2013)PubMed
97.
go back to reference J.E. Curran, J.B. Jowett, K.S. Elliott, Y. Gao, K. Gluschenko, J. Wang, D.M. Abel Azim, G. Cai, M.C. Mahaney, A.G. Comuzzie, T.D. Dyer, K.R. Walder, P. Zimmet, J.W. MacCluer, G.R. Collier, A.H. Kissebah, J. Blangero, Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234–1241 (2005)PubMed J.E. Curran, J.B. Jowett, K.S. Elliott, Y. Gao, K. Gluschenko, J. Wang, D.M. Abel Azim, G. Cai, M.C. Mahaney, A.G. Comuzzie, T.D. Dyer, K.R. Walder, P. Zimmet, J.W. MacCluer, G.R. Collier, A.H. Kissebah, J. Blangero, Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234–1241 (2005)PubMed
98.
go back to reference L.R. Santos, C. Durães, A. Mendes, H. Prazeres, I. Alvelos, C.S. Moreira, P. Canedo, C. Esteves, C. Neves, D. Carvalho, M.S. Simões, P. Soares, A polymorphism in the promoter region of Selenoprotein S gene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab. 99, jc20133539 (2014) L.R. Santos, C. Durães, A. Mendes, H. Prazeres, I. Alvelos, C.S. Moreira, P. Canedo, C. Esteves, C. Neves, D. Carvalho, M.S. Simões, P. Soares, A polymorphism in the promoter region of Selenoprotein S gene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab. 99, jc20133539 (2014)
99.
go back to reference C. Marcocci, G.J. Kahaly, G.E. Krassas, L. Bartalena, M. Prummel, M. Stahl, M.A. Altea, M. Nardi, S. Pitz, K. Boboridis, P. Sivelli, G. von Arx, M.P. Mourits, L. Baldeschi, W. Bencivelli, W. Wiersinga, European Group on Graves’ Orbitopathy. Selenium and the course of mild Graves’ orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011)PubMed C. Marcocci, G.J. Kahaly, G.E. Krassas, L. Bartalena, M. Prummel, M. Stahl, M.A. Altea, M. Nardi, S. Pitz, K. Boboridis, P. Sivelli, G. von Arx, M.P. Mourits, L. Baldeschi, W. Bencivelli, W. Wiersinga, European Group on Graves’ Orbitopathy. Selenium and the course of mild Graves’ orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011)PubMed
100.
go back to reference I. Bülow Pedersen, N. Knudsen, A. Carlé, L. Schomburg, J. Köhrle, T. Jørgensen, L.B. Rasmussen, L. Ovesen, P. Laurberg, Serum selenium is low in newly diagnosed Graves’ disease: a population-based study. Clin. Endocrinol. (Oxf) 79, 584–590 (2013) I. Bülow Pedersen, N. Knudsen, A. Carlé, L. Schomburg, J. Köhrle, T. Jørgensen, L.B. Rasmussen, L. Ovesen, P. Laurberg, Serum selenium is low in newly diagnosed Graves’ disease: a population-based study. Clin. Endocrinol. (Oxf) 79, 584–590 (2013)
101.
go back to reference A. Drutel, F. Archambeaud, P. Caron, Selenium and the thyroid gland: more good news for clinicians. Clin. Endocrinol. (Oxf) 78, 156–164 (2013). doi:10.111/cen.12066 A. Drutel, F. Archambeaud, P. Caron, Selenium and the thyroid gland: more good news for clinicians. Clin. Endocrinol. (Oxf) 78, 156–164 (2013). doi:10.​111/​cen.​12066
102.
go back to reference T. Wertenbruch, H.S. Willenberg, C. Sagert, T.B. Nguyen, M. Bahlo, J. Feldkamp, C. Groeger, D. Hermsen, W.A. Scherbaum, M. Schott, Serum selenium levels in patients with remission and relapse of Graves’ disease. Med. Chem. 3, 281–284 (2007)PubMed T. Wertenbruch, H.S. Willenberg, C. Sagert, T.B. Nguyen, M. Bahlo, J. Feldkamp, C. Groeger, D. Hermsen, W.A. Scherbaum, M. Schott, Serum selenium levels in patients with remission and relapse of Graves’ disease. Med. Chem. 3, 281–284 (2007)PubMed
103.
104.
go back to reference N. Xia, S. Zhou, Y. Liang, C. Xiao, H. Shen, H. Pan, H. Deng, N. Wang, Q.Q. Li, CD4+T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves’ ophthalmopathy. Int. J. Mol. Med. 17, 911–916 (2006)PubMed N. Xia, S. Zhou, Y. Liang, C. Xiao, H. Shen, H. Pan, H. Deng, N. Wang, Q.Q. Li, CD4+T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves’ ophthalmopathy. Int. J. Mol. Med. 17, 911–916 (2006)PubMed
105.
go back to reference L. Kiremidjian-Schumacher, M. Roy, H.I. Wishe, M.W. Cohen, G. Stotzky, Selenium and immune cell functions. I. Effect on lymphocyte proliferation and production of interleukin 1 and interleukin 2. Proc. Soc. Exp. Biol. Med. 193, 136–142 (1990)PubMed L. Kiremidjian-Schumacher, M. Roy, H.I. Wishe, M.W. Cohen, G. Stotzky, Selenium and immune cell functions. I. Effect on lymphocyte proliferation and production of interleukin 1 and interleukin 2. Proc. Soc. Exp. Biol. Med. 193, 136–142 (1990)PubMed
106.
go back to reference Z. Zhang, W. Yu, J.L. Hargrove, P. Greenspan, R.G. Dean, E.W. Taylor, D.K. Hartle, Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 161, 381–386 (2002)PubMed Z. Zhang, W. Yu, J.L. Hargrove, P. Greenspan, R.G. Dean, E.W. Taylor, D.K. Hartle, Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 161, 381–386 (2002)PubMed
107.
108.
go back to reference Z. Huang, A.H. Rose, P.R. Hoffmann, The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16 (2012). doi:10.1089/Ars.2011.4145 Z. Huang, A.H. Rose, P.R. Hoffmann, The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16 (2012). doi:10.​1089/​Ars.​2011.​4145
109.
go back to reference L.B. Rasmussen, L. Schomburg, J. Köhrle, I.B. Pedersen, B. Hollenbach, A. Hög, S. Ovesen, H. Perrild, P. Laurberg, Selenium status, thyroid volume, and multiple nodule formation in a area with mild iodine deficiency. Eur. J. Endocrinol. 164, 585–590 (2011)PubMed L.B. Rasmussen, L. Schomburg, J. Köhrle, I.B. Pedersen, B. Hollenbach, A. Hög, S. Ovesen, H. Perrild, P. Laurberg, Selenium status, thyroid volume, and multiple nodule formation in a area with mild iodine deficiency. Eur. J. Endocrinol. 164, 585–590 (2011)PubMed
110.
go back to reference V.F. Brauer, U. Schweizer, J. Köhrle, R. Paschke, Selenium and goiter prevalence in borderline iodine sufficiency. Eur. J. Endocrinol. 155, 807–812 (2006)PubMed V.F. Brauer, U. Schweizer, J. Köhrle, R. Paschke, Selenium and goiter prevalence in borderline iodine sufficiency. Eur. J. Endocrinol. 155, 807–812 (2006)PubMed
111.
go back to reference H. Derumeaux, P. Valeix, K. Castetbon, M. Bensimon, M.C. Boutron-Ruault, J. Arnaud, S. Hercberg, Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309–315 (2003)PubMed H. Derumeaux, P. Valeix, K. Castetbon, M. Bensimon, M.C. Boutron-Ruault, J. Arnaud, S. Hercberg, Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309–315 (2003)PubMed
112.
go back to reference H. Xue, W. Wang, Y. Li, Z. Shan, Y. Li, X. Teng, Y. Gao, C. Fan, W. Teng, Selenium upregulates CD4 (+) CD25 (+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr. J. 57, 595–601 (2010)PubMed H. Xue, W. Wang, Y. Li, Z. Shan, Y. Li, X. Teng, Y. Gao, C. Fan, W. Teng, Selenium upregulates CD4 (+) CD25 (+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr. J. 57, 595–601 (2010)PubMed
113.
go back to reference C. Balázs, V. Kaczur, Effect of selenium on expression of HLA-DR thyrocytes. Autoimmune Dis. 37, 4635 (2012) C. Balázs, V. Kaczur, Effect of selenium on expression of HLA-DR thyrocytes. Autoimmune Dis. 37, 4635 (2012)
114.
go back to reference R. Krysiak, B. Okopien, The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 96, 2206–2215 (2011). doi:10.1210/jc.2010-2986 PubMed R. Krysiak, B. Okopien, The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 96, 2206–2215 (2011). doi:10.​1210/​jc.​2010-2986 PubMed
115.
go back to reference B.A. Carlson, M.H. Yoo, R.K. Shrimali, R. Irons, V.N. Gladyshev, D.L. Hatfield, J.M. Park, Role of selenium-containing proteins in T-cell and macrophage function. Proc. Nutr. Soc. 69, 300–331 (2010)PubMedCentralPubMed B.A. Carlson, M.H. Yoo, R.K. Shrimali, R. Irons, V.N. Gladyshev, D.L. Hatfield, J.M. Park, Role of selenium-containing proteins in T-cell and macrophage function. Proc. Nutr. Soc. 69, 300–331 (2010)PubMedCentralPubMed
116.
go back to reference R.K. Shrimali, R.D. Irons, B.A. Carlson, Y. Sano, V.N. Gladyshev, J.M. Park, D.L. Hatfield, Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 283, 20181–20185 (2008)PubMedCentralPubMed R.K. Shrimali, R.D. Irons, B.A. Carlson, Y. Sano, V.N. Gladyshev, J.M. Park, D.L. Hatfield, Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 283, 20181–20185 (2008)PubMedCentralPubMed
117.
go back to reference A. Dumitrescu, S. Refetoff, Inherited defects of thyroid hormone metabolism. Ann. Endocrinol. (Paris) 72, 95–98 (2011) A. Dumitrescu, S. Refetoff, Inherited defects of thyroid hormone metabolism. Ann. Endocrinol. (Paris) 72, 95–98 (2011)
118.
go back to reference A.M. Dumitrescu, X.H. Liao, M.S. Abdullah, J. Lado-Abeal, F.A. Majed, L.C. Moeller, G. Boran, L. Schomburg, R.E. Weiss, S. Refetoff, Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247–1252 (2005)PubMed A.M. Dumitrescu, X.H. Liao, M.S. Abdullah, J. Lado-Abeal, F.A. Majed, L.C. Moeller, G. Boran, L. Schomburg, R.E. Weiss, S. Refetoff, Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247–1252 (2005)PubMed
119.
go back to reference M.F. Azevedo, G.B. Barra, L.A. Naves, L.F. Ribeiro Velasco, P. Godoy Garcia Castro, L.C. de Castro, A.A. Amato, A. Miniard, D. Driscoll, L. Schomburg, F. de Assis Rocha Neves, Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066–4071 (2010). doi:10.1210/jc.2009-2611 PubMed M.F. Azevedo, G.B. Barra, L.A. Naves, L.F. Ribeiro Velasco, P. Godoy Garcia Castro, L.C. de Castro, A.A. Amato, A. Miniard, D. Driscoll, L. Schomburg, F. de Assis Rocha Neves, Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066–4071 (2010). doi:10.​1210/​jc.​2009-2611 PubMed
120.
go back to reference E. Shoenmakers, M. Agostini, C. Mitchell, N. Schoenmakers, L. Papp, O. Rajanayagam, R. Padidela, L. Ceron-Gutierrez, R. Döffinger, C. Provost, J. Luan, S. Montano, J. Lu, M. Castanet, N. Clemons, M. Groeneveld, P. Castets, M. Karbaschi, S. Aitken, A. Dixon, J. Williams, I. Campi, M. Blount, H. Burton, F. Muntoni, D. O’Donovan, A. Dean, A. Warren, C. Brierley, D. Baguley, P. Guicheney, R. Fitzgerald, A. Coles, H. Gaston, P. Todd, A. Holmgren, K.K. Khanna, M. Cooke, R. Semple, D. Halsall, N. Wareham, J. Schwabe, L. Grasso, P. Beck-Peccoz, A. Ogunko, M. Dattani, M. Gurnell, K. Chatterjee, Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220–4235 (2010) E. Shoenmakers, M. Agostini, C. Mitchell, N. Schoenmakers, L. Papp, O. Rajanayagam, R. Padidela, L. Ceron-Gutierrez, R. Döffinger, C. Provost, J. Luan, S. Montano, J. Lu, M. Castanet, N. Clemons, M. Groeneveld, P. Castets, M. Karbaschi, S. Aitken, A. Dixon, J. Williams, I. Campi, M. Blount, H. Burton, F. Muntoni, D. O’Donovan, A. Dean, A. Warren, C. Brierley, D. Baguley, P. Guicheney, R. Fitzgerald, A. Coles, H. Gaston, P. Todd, A. Holmgren, K.K. Khanna, M. Cooke, R. Semple, D. Halsall, N. Wareham, J. Schwabe, L. Grasso, P. Beck-Peccoz, A. Ogunko, M. Dattani, M. Gurnell, K. Chatterjee, Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220–4235 (2010)
121.
go back to reference C. Di Cosmo, N. McLellan, X.H. Liao, K.K. Khanna, R.E. Weiss, L. Papp, S. Refetoff, Clinical and molecular characterization of nine selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J. Clin. Endocrinol. Metab. 94, 4003–4009 (2009)PubMedCentralPubMed C. Di Cosmo, N. McLellan, X.H. Liao, K.K. Khanna, R.E. Weiss, L. Papp, S. Refetoff, Clinical and molecular characterization of nine selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J. Clin. Endocrinol. Metab. 94, 4003–4009 (2009)PubMedCentralPubMed
122.
go back to reference L. Schomburg, A.M. Dumitrescu, X.H. Liao, B. Bin-Abbas, J. Hoeflich, J. Köhrle, S. Refetoff, Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19, 277–281 (2009)PubMedCentralPubMed L. Schomburg, A.M. Dumitrescu, X.H. Liao, B. Bin-Abbas, J. Hoeflich, J. Köhrle, S. Refetoff, Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19, 277–281 (2009)PubMedCentralPubMed
123.
go back to reference J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium and diabetes in U.S adults. Diabetes Care 30, 829–834 (2007)PubMed J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium and diabetes in U.S adults. Diabetes Care 30, 829–834 (2007)PubMed
124.
go back to reference M. Laclaustra, A. Navas-Acien, S. Stranges, J.M. Ordovas, E. Guallar, Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ. Health Perspect. 117, 1409–1413 (2009). doi:10.1289/ehp.0900704 PubMedCentralPubMed M. Laclaustra, A. Navas-Acien, S. Stranges, J.M. Ordovas, E. Guallar, Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ. Health Perspect. 117, 1409–1413 (2009). doi:10.​1289/​ehp.​0900704 PubMedCentralPubMed
125.
go back to reference S. Stranges, J.R. Marshall, R. Natarajan, R.P. Donahue, M. Trevisan, G.F. Combs, F.P. Cappuccio, A. Ceriello, M.E. Reid, Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Int. Med. 147, 217–223 (2007)PubMed S. Stranges, J.R. Marshall, R. Natarajan, R.P. Donahue, M. Trevisan, G.F. Combs, F.P. Cappuccio, A. Ceriello, M.E. Reid, Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Int. Med. 147, 217–223 (2007)PubMed
126.
go back to reference S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, L.G. Ford, H.L. Parnes, L.M. Minasian, J.M. Gaziano, J.A. Hartline, J.K. Parsons, J.D. Bearden 3rd, E.D. Crawford, G.E. Goodman, J. Claudio, E. Winquist, E.D. Cook, D.D. Karp, P. Walther, M.M. Lieber, A.R. Kristal, A.K. Darke, K.B. Arnold, P.A. Ganz, R.M. Santella, D. Albanes, P.R. Taylor, J.L. Probstfield, T.J. Jagpal, J.J. Crowley, F.L. Meyskens Jr, L.H. Baker and C.A. Coltman Jr., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301, 39–51 (2009) S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, L.G. Ford, H.L. Parnes, L.M. Minasian, J.M. Gaziano, J.A. Hartline, J.K. Parsons, J.D. Bearden 3rd, E.D. Crawford, G.E. Goodman, J. Claudio, E. Winquist, E.D. Cook, D.D. Karp, P. Walther, M.M. Lieber, A.R. Kristal, A.K. Darke, K.B. Arnold, P.A. Ganz, R.M. Santella, D. Albanes, P.R. Taylor, J.L. Probstfield, T.J. Jagpal, J.J. Crowley, F.L. Meyskens Jr, L.H. Baker and C.A. Coltman Jr., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301, 39–51 (2009)
127.
go back to reference J. Arnaud, T.N. Akbaraly, I. Hininger, A.M. Roussel, C. Berr, Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. J. Nutr. Biochem. 18, 482–487 (2007)PubMedCentralPubMed J. Arnaud, T.N. Akbaraly, I. Hininger, A.M. Roussel, C. Berr, Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. J. Nutr. Biochem. 18, 482–487 (2007)PubMedCentralPubMed
128.
go back to reference N.T. Akbaraly, J. Arnaud, I. Favier Hininger, V. Gourlet, A.M. Roussel, C. Berr, Selenium and mortality in the elderly: results from the EVA study. Clin. Chem. 51, 2117–2123 (2005)PubMed N.T. Akbaraly, J. Arnaud, I. Favier Hininger, V. Gourlet, A.M. Roussel, C. Berr, Selenium and mortality in the elderly: results from the EVA study. Clin. Chem. 51, 2117–2123 (2005)PubMed
129.
go back to reference S. Mao, A. Zhang, S. Huang, Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Endocrine (2014) Epub ahead of print S. Mao, A. Zhang, S. Huang, Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Endocrine (2014) Epub ahead of print
131.
go back to reference J.N. Hellwege, N.D. Palmer, J.T. Ziegler, C.D. Langefeld, C. Lorenzo, J.M. Norris, T. Takamura, D.W. Bowden, Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 534, 33–39 (2014)PubMed J.N. Hellwege, N.D. Palmer, J.T. Ziegler, C.D. Langefeld, C. Lorenzo, J.M. Norris, T. Takamura, D.W. Bowden, Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 534, 33–39 (2014)PubMed
132.
go back to reference B.J. Ko, S.M. Kim, K.H. Park, H.S. Park, C.S. Mantzoros, Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children. Int. J. Obes. (Lond) 18 (2014). doi:10.1038/ijo.2014.45 B.J. Ko, S.M. Kim, K.H. Park, H.S. Park, C.S. Mantzoros, Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children. Int. J. Obes. (Lond) 18 (2014). doi:10.​1038/​ijo.​2014.​45
133.
135.
go back to reference C. Kornhauser, J.R. Garcia-Ramirez, K. Wrobel, E.L. Pérez-Luque, M.E. Garay-Sevilla, K. Wrobel, Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim. Care Diabetes. 2, 81–85 (2008)PubMed C. Kornhauser, J.R. Garcia-Ramirez, K. Wrobel, E.L. Pérez-Luque, M.E. Garay-Sevilla, K. Wrobel, Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim. Care Diabetes. 2, 81–85 (2008)PubMed
136.
go back to reference M. Navarro-Alarcón, H. López-G de la Serrana, V. Pérez-Valero, C. López-Martínez, Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci. Total Environ. 228, 79–88 (1999)PubMed M. Navarro-Alarcón, H. López-G de la Serrana, V. Pérez-Valero, C. López-Martínez, Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci. Total Environ. 228, 79–88 (1999)PubMed
137.
go back to reference H. Steinbrenner, B. Speckmann, A. Pinto, H. Sies, High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 48, 40–45 (2011)PubMedCentralPubMed H. Steinbrenner, B. Speckmann, A. Pinto, H. Sies, High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 48, 40–45 (2011)PubMedCentralPubMed
138.
go back to reference A. Pinto, D.T. Juniper, M. Sanil, L. Morgan, L. Clark, H. Sies, M.P. Rayman, H. Steinbrenner, Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 114, 47–54 (2012). doi:10.1016/j.jinorgbio.2012.04.011 PubMed A. Pinto, D.T. Juniper, M. Sanil, L. Morgan, L. Clark, H. Sies, M.P. Rayman, H. Steinbrenner, Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 114, 47–54 (2012). doi:10.​1016/​j.​jinorgbio.​2012.​04.​011 PubMed
140.
go back to reference A.S. Mueller, J. Pallauf, Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J. Nutr. Biochem. 17, 548–560 (2006)PubMed A.S. Mueller, J. Pallauf, Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J. Nutr. Biochem. 17, 548–560 (2006)PubMed
141.
go back to reference C. Wang, S. Yang, N. Zhang, Y. Mu, H. Ren, Y. Wang, K. Li, Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One 9, e101315 (2014). doi:10.1371/journal.pone.0101315 PubMedCentralPubMed C. Wang, S. Yang, N. Zhang, Y. Mu, H. Ren, Y. Wang, K. Li, Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One 9, e101315 (2014). doi:10.​1371/​journal.​pone.​0101315 PubMedCentralPubMed
142.
go back to reference C.R. Rocourt, W.H. Cheng, Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients 5, 1349–1365 (2013)PubMedCentralPubMed C.R. Rocourt, W.H. Cheng, Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients 5, 1349–1365 (2013)PubMedCentralPubMed
144.
145.
go back to reference M.P. Rayman, S. Stranges, Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic. Biol. Med. 65, 1557–1564 (2013)PubMed M.P. Rayman, S. Stranges, Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic. Biol. Med. 65, 1557–1564 (2013)PubMed
146.
go back to reference M.P. Rayman, Selenium and human health. Lancet 379, 1256–1268 (2012)PubMed M.P. Rayman, Selenium and human health. Lancet 379, 1256–1268 (2012)PubMed
147.
148.
go back to reference L. Flohé, Selenium in mammalian spermiogenesis. Biol. Chem. 388, 987–995 (2007)PubMed L. Flohé, Selenium in mammalian spermiogenesis. Biol. Chem. 388, 987–995 (2007)PubMed
149.
go back to reference G.E. Olson, V.P. Winfrey, S.K. Nagdas, K.E. Hill, R.F. Burk, Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J. Biol. Chem. 282, 12290–12297 (2007)PubMed G.E. Olson, V.P. Winfrey, S.K. Nagdas, K.E. Hill, R.F. Burk, Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J. Biol. Chem. 282, 12290–12297 (2007)PubMed
150.
go back to reference D. Behne, H. Weiler, A. Kyriakopoulos, Effects of selenium deficiency on testicular morphology and function in rats. J. Reprod. Fertil. 106, 291–297 (1996)PubMed D. Behne, H. Weiler, A. Kyriakopoulos, Effects of selenium deficiency on testicular morphology and function in rats. J. Reprod. Fertil. 106, 291–297 (1996)PubMed
151.
go back to reference N.B. Oldereid, Y. Thomassen, K. Purvis, Selenium in human male reproductive organs. Hum. Reprod. 13, 2172–2176 (1998)PubMed N.B. Oldereid, Y. Thomassen, K. Purvis, Selenium in human male reproductive organs. Hum. Reprod. 13, 2172–2176 (1998)PubMed
152.
go back to reference C. Foresta, L. Flohe, A. Garolla, A. Roveri, F. Ursini, M. Maiorino, Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol. Reprod. 67, 967–971 (2002)PubMed C. Foresta, L. Flohe, A. Garolla, A. Roveri, F. Ursini, M. Maiorino, Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol. Reprod. 67, 967–971 (2002)PubMed
153.
go back to reference K. Nayernia, M. Diaconu, G. Aumüller, G. Wennemuth, I. Schwandt, K. Kleene, H. Kuehn, W. Engel, Phospholipid hydroperoxide glutathione peroxidase: expression pattern during testicular development in mouse and evolutionary conservation in spermatozoa. Mol. Reprod. Dev. 67, 458–464 (2004)PubMed K. Nayernia, M. Diaconu, G. Aumüller, G. Wennemuth, I. Schwandt, K. Kleene, H. Kuehn, W. Engel, Phospholipid hydroperoxide glutathione peroxidase: expression pattern during testicular development in mouse and evolutionary conservation in spermatozoa. Mol. Reprod. Dev. 67, 458–464 (2004)PubMed
154.
go back to reference F. Ursini, S. Heim, M. Kiess, M. Maiorino, A. Roveri, J. Wissing, L. Flohe, Dual function of the selenoprotein PHGPX during sperm maturation. Science 285, 1393–1396 (1999)PubMed F. Ursini, S. Heim, M. Kiess, M. Maiorino, A. Roveri, J. Wissing, L. Flohe, Dual function of the selenoprotein PHGPX during sperm maturation. Science 285, 1393–1396 (1999)PubMed
155.
go back to reference M. Maiorino, J.B. Wissing, R. Brigelius-Flohé, F. Calabrese, A. Roveri, P. Steinert, F. Ursini, L. Flohé, Testosterone mediates expression of the selenoprotein PHGPX by induction of spermatogenesis and not by direct transcriptional gene activation. FASEB J. 12, 1359–1370 (1998)PubMed M. Maiorino, J.B. Wissing, R. Brigelius-Flohé, F. Calabrese, A. Roveri, P. Steinert, F. Ursini, L. Flohé, Testosterone mediates expression of the selenoprotein PHGPX by induction of spermatogenesis and not by direct transcriptional gene activation. FASEB J. 12, 1359–1370 (1998)PubMed
156.
go back to reference M. Michaelis, O. Gralla, T. Behrends, M. Scharpf, T. Endermann, E. Rijntjes, N. Pietschmann, B. Hollenbach, L. Schomburg, Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem. Biophys. Res. Commun. 443, 905–910 (2014). doi:10.1016/j.bbrc.2013.12.06 PubMed M. Michaelis, O. Gralla, T. Behrends, M. Scharpf, T. Endermann, E. Rijntjes, N. Pietschmann, B. Hollenbach, L. Schomburg, Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem. Biophys. Res. Commun. 443, 905–910 (2014). doi:10.​1016/​j.​bbrc.​2013.​12.​06 PubMed
157.
go back to reference M. Mirone, E. Giannetta, A.M. Isidori, Selenium and reproductive function. A systematic review. J. Endocrinol. Invest. 36, 28–36 (2013)PubMed M. Mirone, E. Giannetta, A.M. Isidori, Selenium and reproductive function. A systematic review. J. Endocrinol. Invest. 36, 28–36 (2013)PubMed
158.
go back to reference R. Scott, A. MacPherson, R.W. Yates, B. Hussain, J. Dixon, The effect of oral selenium supplementation on human sperm motility. Br. J. Urol. 82, 76–80 (1998)PubMed R. Scott, A. MacPherson, R.W. Yates, B. Hussain, J. Dixon, The effect of oral selenium supplementation on human sperm motility. Br. J. Urol. 82, 76–80 (1998)PubMed
160.
go back to reference A. Duncan, D. Talwar, D.C. McMillan, F. Stefanowicz, D.S. O’Reilly, Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am. J. Clin. Nutr. 95, 64–71 (2012). doi:10.3945/ajcn.111.023812 PubMed A. Duncan, D. Talwar, D.C. McMillan, F. Stefanowicz, D.S. O’Reilly, Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am. J. Clin. Nutr. 95, 64–71 (2012). doi:10.​3945/​ajcn.​111.​023812 PubMed
162.
go back to reference O.A. Levander, M.A. Beck, Selenium and viral virulence. Brit. Med. Bull. 55, 5528–5533 (1999) O.A. Levander, M.A. Beck, Selenium and viral virulence. Brit. Med. Bull. 55, 5528–5533 (1999)
163.
go back to reference M.A. Beck, Q. Shi, V.C. Morris, O.A. Levander, Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1, 433–436 (1995)PubMed M.A. Beck, Q. Shi, V.C. Morris, O.A. Levander, Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1, 433–436 (1995)PubMed
164.
go back to reference M.A. Beck, R.S. Esworthy, Y.S. Ho, F.F. Chu, Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12, 1143–1149 (1998)PubMed M.A. Beck, R.S. Esworthy, Y.S. Ho, F.F. Chu, Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12, 1143–1149 (1998)PubMed
165.
go back to reference L. Yu, L. Sun, Y. Nan, L.Y. Zhu, Protection from H1N1 influenza virus infections in mice by supplementation with selenium: a comparison with selenium-deficient mice. Biol. Trace Elem. Res. 141, 254–261 (2011)PubMed L. Yu, L. Sun, Y. Nan, L.Y. Zhu, Protection from H1N1 influenza virus infections in mice by supplementation with selenium: a comparison with selenium-deficient mice. Biol. Trace Elem. Res. 141, 254–261 (2011)PubMed
166.
167.
go back to reference I. Jaspers, W. Zhang, L.E. Brighton, J.L. Carson, M. Styblo, M.A. Beck, Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic. Biol. Med. 42, 1826–1837 (2007)PubMedCentralPubMed I. Jaspers, W. Zhang, L.E. Brighton, J.L. Carson, M. Styblo, M.A. Beck, Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic. Biol. Med. 42, 1826–1837 (2007)PubMedCentralPubMed
168.
go back to reference S.J. Allsup, A. Shenkin, M.A. Gosney, S. Taylor, W. Taylor, M. Hammond, M.C. Zambon, Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J. Am. Geriatr. Soc. 52, 20–24 (2004)PubMed S.J. Allsup, A. Shenkin, M.A. Gosney, S. Taylor, W. Taylor, M. Hammond, M.C. Zambon, Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J. Am. Geriatr. Soc. 52, 20–24 (2004)PubMed
169.
go back to reference C.S. Broome, F. McArdle, J.A. Kyle, F. Andrews, N.M. Lowe, C.A. Hart, J.R. Arthur, M.J. Jackson, An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am. J. Clin. Nutr. 80, 154–162 (2004)PubMed C.S. Broome, F. McArdle, J.A. Kyle, F. Andrews, N.M. Lowe, C.A. Hart, J.R. Arthur, M.J. Jackson, An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am. J. Clin. Nutr. 80, 154–162 (2004)PubMed
171.
go back to reference M.C. Rousseau, C. Molines, J. Moreau, J. Delmont, Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann. Nutr. Metab. 44, 212–216 (2000)PubMed M.C. Rousseau, C. Molines, J. Moreau, J. Delmont, Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann. Nutr. Metab. 44, 212–216 (2000)PubMed
172.
go back to reference G. Shor-Posner, M.J. Miguez, L.M. Pineda, A. Rodriguez, P. Ruiz, G. Castillo, X. Burbano, R. Lecusay, M. Baum, Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 29, 169–173 (2002)PubMed G. Shor-Posner, M.J. Miguez, L.M. Pineda, A. Rodriguez, P. Ruiz, G. Castillo, X. Burbano, R. Lecusay, M. Baum, Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 29, 169–173 (2002)PubMed
173.
go back to reference X. Forceville, D. Vitoux, Selenium systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit. Care Med. 26, 1536–1544 (1998)PubMed X. Forceville, D. Vitoux, Selenium systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit. Care Med. 26, 1536–1544 (1998)PubMed
174.
go back to reference C. Sanmartin, D. Plano, M. Font, J.A. Palop, Selenium and clinical trials: new therapeutic evidence for multiple diseases. Curr. Med. Chem. 18, 4635–4650 (2011)PubMed C. Sanmartin, D. Plano, M. Font, J.A. Palop, Selenium and clinical trials: new therapeutic evidence for multiple diseases. Curr. Med. Chem. 18, 4635–4650 (2011)PubMed
175.
go back to reference J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium levels and all-cause, cancer and cardiovascular mortality among US adults. Arch. Int. Med. 168, 404–410 (2008) J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium levels and all-cause, cancer and cardiovascular mortality among US adults. Arch. Int. Med. 168, 404–410 (2008)
176.
go back to reference W. Alhazzani, J. Jacobi, A. Sindi, C. Hartog, K. Reinhart, S. Kokkoris, H. Gerlach, P. Andrews, T. Drabek, W. Manzanares, D.J. Cook, R.Z. Jaeschke, The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 41, 1555–1564 (2013)PubMed W. Alhazzani, J. Jacobi, A. Sindi, C. Hartog, K. Reinhart, S. Kokkoris, H. Gerlach, P. Andrews, T. Drabek, W. Manzanares, D.J. Cook, R.Z. Jaeschke, The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 41, 1555–1564 (2013)PubMed
Metadata
Title
Selenium: an element for life
Authors
Leonidas H. Duntas
Salvatore Benvenga
Publication date
01-04-2015
Publisher
Springer US
Published in
Endocrine / Issue 3/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0477-6

Other articles of this Issue 3/2015

Endocrine 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.